Sign up for our eNews and discover more about what we're up to, the difference we're making, and, most importantly, how you can help.
14 May, 2013
Ita Buttrose has presented one of Australia’s most eminent dementia researchers, Professor Henry Brodaty, with the Lifetime Alzheimer’s Australia Award at the official opening of Dementia Australia’s 15th National Conference in Hobart.
Australian of the Year 2013 and Alzheimer’s Australia National President, Ms Buttrose said the award recognises Professor Brodaty’s long-standing commitment to improving the quality of life for people living with dementia.
“Professor Brodaty has dedicated a lifetime of leadership, clinical excellence and research to improve the quality of life for people with dementia, particularly Alzheimer’s disease,” Ms Buttrose said.
“He has made, and continues to make, an outstanding contribution to Australia’s fight against dementia.”
Professor Brodaty is the Scientia Professor of Ageing and Mental Health and Director of the Dementia Collaborative Research Centre at the University of New South Wales. He helped found Alzheimer’s Australia 31 years ago and was its president from 1988-1991.
“Professor Brodaty’s passion, hard work and generosity have been and remain an important contributor to the strong organisation that Alzheimer’s Australia has become today, one which has credibility within Australia and internationally,” Ms Buttrose said.
Ms Buttrose also presented Dr Simon Bell with the 2012 Resthaven inc Dementia Research Award for a project which is looking at appropriate pain management in people with dementia in residential care.
Dr Bell is a pharmacist and Associate Professor, Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia. He is also Adjunct Professor of Geriatric Pharmacotherapy, Faculty of Health Sciences, University of Eastern Finland. His research is mainly focused on studying and optimising the outcomes of psychotropic medicine use, particularly among older people.
“When finalised, Dr Bell’s project will enable clinicians to assess the risks and benefits of prescribing, dispensing and administering medicines with analgesic and sedative properties to people with and without dementia,” Ms Buttrose said.
The Alzheimer’s Australia 15th National Conference will bring together world leaders in social and medical dementia research. Key speakers from Australia, New Zealand, the United Kingdom, the United States and Germany will discuss ways society can successfully challenge dementia through promoting awareness, rehabilitation, social engagement, creativity and self-expression. They will also discuss the need for increased investment in dementia research to identify the cause, treatments and cure for dementia.
The conference program can be found at www.alzheimers2013.com
To download this media release, click here.